The proposed new international TNM staging system for malignant pleural mesothelioma: application to imaging.

Published

Journal Article

Malignant pleural mesothelioma (MPM) is an uncommon and usually fatal primary neoplasm of the pleura. In the past, response to standard therapy has been poor [1-3], but recent studies suggest that some patients may benefit from various therapeutic options, including surgical resection, combined technique treatment, and immunotherapy [4-7]. With improvements in therapy, an accurate, widely accepted staging system will be important in selecting homogeneous groups of patients for entry into clinical trials. Multiple staging systems have previously been proposed for MPM, but none are universally used [8].

Full Text

Duke Authors

Cited Authors

  • Patz, EF; Rusch, VW; Heelan, R

Published Date

  • February 1996

Published In

Volume / Issue

  • 166 / 2

Start / End Page

  • 323 - 327

PubMed ID

  • 8553940

Pubmed Central ID

  • 8553940

International Standard Serial Number (ISSN)

  • 0361-803X

Digital Object Identifier (DOI)

  • 10.2214/ajr.166.2.8553940

Language

  • eng

Conference Location

  • United States